Furthermore, previous studies have shown cognitive decline is associated with higher amyloid-PET (Koscik et al., 2020), hippocampal atrophy on MRI, hypometabolism on FDG-PET, and greater tau levels (Mielke et al., 2017). This evidence concerns the gene MAPT and Mental deterioration.